| Popis: |
There are many treatment guidelines for primary liver cancer, among which Barcelona Clinic Liver Cancer (BCLC) is commonly used as the reference for the treatment of liver cancer in the world; however, only BCLC stage B patients meet the indication for transarterial chemoembolization (TACE), which limits the clinical application of TACE. Therefore, several scoring systems for evaluating prognosis after TACE have been developed in recent years and provide an important reference for the treatment of primary liver cancer. This article introduces the application of scoring systems for evaluating prognosis after TACE and points out their advantages/disadvantages and performance, in order to provide a theoretical basis for the treatment of liver cancer. |
